The Mark Foundation For Cancer Research Merges With Samuel Waxman Cancer Research Foundation

April 1, 2026

The Mark Foundation For Cancer Research has finalized its merger with the Samuel Waxman Cancer Research Foundation to accelerate innovation in cancer science. The combined effort includes the Samuel Waxman Institute for Aging–Cancer (operating as a subsidiary of The Mark Foundation) and plans to fund $15 million over its first three years focused on aging as a leading risk factor for cancer.

Buyers
The Mark Foundation For Cancer Research
Targets
Samuel Waxman Cancer Research Foundation, Samuel Waxman Institute for Aging–Cancer
Location
United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.